Therapy-refractory gastrointestinal motility disorder in a child with c-kit mutations.
about
Gastrointestinal neuromuscular pathology in chronic constipationNPs/NPRs Signaling Pathways May Be Involved in Depression-Induced Loss of Gastric ICC by Decreasing the Production of mSCF.Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics.Development and developmental disorders of the enteric nervous system.Therapeutic effect of protease-activated receptor 2 agonist SLIGRL-NH on loperamide-induced Sprague-Dawley rat constipation model and the related mechanism
P2860
Therapy-refractory gastrointestinal motility disorder in a child with c-kit mutations.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Therapy-refractory gastrointestinal motility disorder in a child with c-kit mutations.
@en
Therapy-refractory gastrointestinal motility disorder in a child with c-kit mutations.
@nl
type
label
Therapy-refractory gastrointestinal motility disorder in a child with c-kit mutations.
@en
Therapy-refractory gastrointestinal motility disorder in a child with c-kit mutations.
@nl
prefLabel
Therapy-refractory gastrointestinal motility disorder in a child with c-kit mutations.
@en
Therapy-refractory gastrointestinal motility disorder in a child with c-kit mutations.
@nl
P2093
P2860
P356
P1476
Therapy-refractory gastrointestinal motility disorder in a child with c-kit mutations.
@en
P2093
Birgit Kuch
Ertan Mayatepek
Gerhard-J Molderings
Rüdiger Adam
P2860
P304
P356
10.3748/WJG.V16.I34.4363
P407
P577
2010-09-01T00:00:00Z